Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Stocks
Currencies
Cryptocurrencies
Metals
Indices
Commodities
ETFs
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
News
Top Providers News
Top Providers News
Symbols
Market
Provider
Time
Symbols
News
Provider
2026.11.04
Bio-Rad Laboratories Affirms FY2026 Sales Guidance of $2.506B-$2.596B vs $2.588B Est
Benzinga
2026.11.04
Atmos Energy Board Chairman Kim R. Cocklin Plans To Retire In 2027; President, CEO J. Kevin Akers To Be Named Successor
Benzinga
2026.11.04
Global Net Lease Raises FY2026 AFFO Guidance from $0.82-$0.85 to $0.83-$0.85 vs $0.85 Est
Benzinga
2026.11.04
Carriage Services Lowers FY2026 Adj EPS Guidance from $3.35-$3.55 to $2.90-$3.05 vs $3.37 Est; Lowers FY2026 Sales Guidance from $435.000M-$445.000M to $415.000M-$420.000M vs $432.548M Est
Benzinga
2026.11.04
Ardent Health Raises FY2026 GAAP EPS Guidance from $0.78-$1.15 to $0.93-$1.18 vs $0.95 Est; Affirms FY2026 Sales Guidance of $6.400B-$6.700B vs $6.463B Est
Benzinga
2026.11.04
Atmos Energy Raises Quarterly Dividend From $1 To $1.09 Per Share
Benzinga
2026.11.04
MercadoLibre Stock Moves Lower After Mixed Q3 Results
Benzinga
2026.11.04
Park Hotels & Resorts Raises FY2026 AFFO Guidance from $1.90-$2.00 to $2.00-$2.05 vs $1.95 Est
Benzinga
2026.11.04
Coty Sees Q2 Adj EPS $0.16-$0.18 vs $0.16 Est
Benzinga
2026.11.04
Citigroup Maintains Buy on Gaming and Leisure Props, Lowers Price Target to $49
Benzinga
2026.11.04
RLJ Lodging Trust Raises FY2026 FFO Guidance from $1.37-$1.50 to $1.47-$1.51 vs $1.46 Est
Benzinga
2026.11.04
Niagen Bioscience Raises FY2026 Sales Guidance from $138.982M-$145.299M to $145.299M-$151.616M vs $130.410M Est
Benzinga
2026.11.04
Ascent Industries Q3 EPS $0.15 Up From $(0.01) YoY, Sales $27.135M Up From $19.697M YoY
Benzinga
2026.11.04
Agilon Health Q3 EPS $1.97 Beats $(1.46) Estimate, Sales $1.519B Beat $1.461B Estimate
Benzinga
2026.11.04
UPDATE: Edwards Lifesciences Raises FY2026 Adj EPS Guidance from $2.95-$3.05 to $2.97-$3.05 vs $3.00 Est; Narrows FY2026 Sales Guidance from $6.600B-$6.900B to $6.766B vs $6.767B Est
Benzinga
2026.11.04
Accuray Announces 1-For-40 Reverse Stock Split, Effective Nov. 9
Benzinga
2026.11.04
Enact Holdings Q3 Adj. EPS $1.19 Beats $1.18 Estimate, Sales $312.854M Miss $317.921M Estimate
Benzinga
2026.11.04
Maravai LifeSciences Raises FY2026 Sales Guidance from $205.000M-$215.000M to $212.000M-$216.000M vs $211.767M Est
Benzinga
2026.11.04
Mativ Holdings Q3 Adj. EPS $0.31 Beats $0.25 Estimate, Sales $499.500M Miss $510.000M Estimate
Benzinga
2026.11.04
Magnite Sees Q4 Total Contribution ex-TAC $227.000M-$233.000M vs $218.978M Est
Benzinga
2026.11.04
Edwards Lifesciences Narrows FY2026 Sales Guidance from $6.600B-$6.900B to $6.766B vs $6.767B Est
Benzinga
2026.11.04
Viavi Solutions Q1 Adj. EPS $0.47 Beats $0.41 Estimate, Sales $469.300M Beat $455.063M Estimate
Benzinga
2026.11.04
Celanese Announces Asia Price Increases Of $0.20/kg For PA66 And $0.30/kg For PA6, PBT And PET Products, Including Zytel, Frianyl, Celanyl, Minlon, CoolPoly, Ecomid, Crastin, Celanex And Rynite
Benzinga
2026.11.04
Macerich Q3 FFO $0.37, Inline, Sales $260.067M Beat $248.265M Estimate
Benzinga
2026.11.04
CoreCivic Q3 FFO $0.84 Beats $0.65 Estimate, Sales $744.094M Beat $697.549M Estimate
Benzinga
2026.11.04
Unisys Q3 Adj. EPS $(0.12) Beats $(0.23) Estimate, Sales $471.500M Beat $449.850M Estimate
Benzinga
2026.11.04
Arm Shares Slip Despite Q2 Double-Beat: Details
Benzinga
2026.11.04
Progyny Sees Q4 GAAP EPS $0.36-$0.41 vs $0.34 Est
Benzinga
2026.11.04
Citigroup Maintains Neutral on AMETEK, Raises Price Target to $270
Benzinga
2026.11.04
Cadre Hldgs Q3 EPS $0.27 Misses $0.28 Estimate, Sales $202.876M Beat $190.647M Estimate
Benzinga
1
...
255
256
257
258
259
260
...
712
>